Brief: Gen Ilac Says It Signs Distributorship Agreement By 3-Years With France-Based Balt International Sas
26/11/2025 12:42
Nov 26 (Reuters) - Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret GENIL.IS: GEN ILAC- SIGNS DISTRIBUTORSHIP AGREEMENT BY 3-YEARS WITH FRANCE-BASED BALT INTERNATİONAL SAS GEN ILAC - AGREEMENT IS EXPECTED TO CONTRIBUTE BETWEEN EUR 15.0 MILLION AND EUR 16.0 MILLION TO GEN'S SALES IN 2026 GEN ILAC - TO BE THE EXCLUSIVE AUTHORITY FOR SUPPLY AND DISTRIBUTION ACTIVITIES IN TURKEY OF VARIOUS MEDICAL DEVICES DEVELOPED AND MANUFACTURED BY BALT Source text: nIKA8GPpXc Further company coverage: GENIL.IS (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com;; +48 58 7696600;))
Recent news on Gen Ilac ve Saglik Urunleri Sanayi Ticaret
See all newsBrief: Gen Ilac Says It Wins Pharmaceutical Tender In Kazakhstan, Expects $1.19 Million Sales Contribution In 2027
Brief: Gen Ilac Says It Participates In Kazakhstan Drug Procurement Tender Via Med Service Plus Authorized By Kazakhstan Representative Office Of Gen Ilac
Brief: Gen Ilac Says It Signs Supply And Distribution Agreement With Incyte On Oct 9
Brief: Gen Ilac Says It Completes Pharmaceutical Manufacturing Plant Investment In Azerbaijan
Brief: Gen Ilac Says It Is To Start Share Buyback Programme For Max 125 Mln Nominal Shares With Allocated Funds Of 1.5 Bln Lira